Global Bone Densitometer Market 2022-2028
MARKET OUTLOOK
A report by Triton Market Research insinuates that the global bone densitometer market would register growth at a CAGR of 4.66% over the projected years 2022-2028.
The rise in the cases of degenerative joint diseases is one of the prime driving forces of the bone densitometer market. Moreover, the growing prevalence of osteoporosis is also adding to the market’s growth.
On the contrary, the lack of public awareness about bone densitometers is hindering this growth process. Other factors impeding the market growth include risks associated with the use of bone densitometers and their high price. However, the continuous technological advancements are expected to generate multiple avenues for the market growth in the years to come.
REGIONAL OUTLOOK
The global market for bone densitometer covers Europe, the Asia-Pacific, Latin America, North America, and the Middle East and Africa.
The market in the Asia-Pacific is expected to evolve the fastest globally, in the forthcoming years. The growing population in countries like China and India, along with the enhanced life expectancy, have resulted in an increase in the geriatric population. This, in turn, has increased the demand for bone densitometers, as people in this age group are more likely to need them. Factors such as these are driving the growth of the bone densitometer market in the APAC.
COMPETITIVE OUTLOOK
The key players in the bone densitometer market include Diagnostic Medical System Group, Scanflex Healthcare AB, Hologic Inc, Medilink, Trivitron Healthcare, Oscar Medical Oy, GE Healthcare, Swissray Global Healthcare Holding Ltd, Osteometer MediTech Inc, L Acn L Accessorio Nucleare Srl, Medonica Co Ltd, Eurotec Systems Srl, BeamMed Ltd, OSI Systems Inc, and Echolight SpA.
GE Healthcare is a leading global medical technology company and an innovator in the field of diagnostics. The company, through its intelligent devices, applications, data analytics, and services, enables clinicians to make faster and more informed decisions. GE provides its services in over 160 countries worldwide.
In FY 2020, its revenue was $18,009 million. The company has a workforce of more than 47000 employees. GE Healthcare was incorporated in 1994. With a large focus on research and development, the company invests nearly $1 billion in R&D activities annually. Lunar iDXA and Prodigy are key products in its bone densitometry range.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook